Recipients
EFSD/Pfizer European Programme for Research into Cardiovascular Risk Reduction in Patients with Diabetes



2010:

Magnus Jensen - Gentofte University Hospital - Denmark
Early detection of cardiac dysfunction with tissue Doppler imaging echocardiography in patients with type 1 diabetes; the one thousand and one study

Claudia Menzaghi - IRCCS - San Giovanni Rotondo, Italy
Resistin and cardiovascular disease in type 2 diabetes

2009:

Amalia Gastaldelli - Institute of Clinical Physiology - Pisa, Italy
Use of simple imaging and intravascular markers for early detection of coronary heart (CHD) and/or cardiovascular (CVD) disease (IMVASC)

David Halon - Lady Davis Carmel Medical Center - Haifa, Israel
Assessment of the value of coronary atherosclerotic plaque analysis by computed tomographic angiography of the coronary arteries in the prediction of acute cardiac events in asymptomatic individuals with type 2 diabetes mellitus

2008:

Knut Borch-Johnsen - Steno Diabetes Center - Gentofte, Denmark
Risk of cardiovascular disease in individuals responding to a high-risk screening programme for diabetes.  The ADDITION study, Denmark

Marju Orho-Melander
- Lund University - Malnö, Sweden
Identification of novel regulators of circulating lipid levels and development of a genetic risk engine for cardiovascular disease

2007:

In 2007, no grants were awarded for this Programme.

2006:

David Dunger - Cambridge University - United Kingdom
The UK Genetic Resource Investigating Diabetes (GRID)

Daisy Flamez - Free University Brussels - Belgium
Use of the Wiki-approach to make the "Beta Cell Gene Expression Bank" an open and self-sustained resource database

2005:

Piero Marchetti - Cisanello Hospital - Pisa, Italy
Implementation of a resource to make available pancreas and pancreatic islet samples for morphological, biological and molecular studies

2004:

Knut Borch-Johnsen - Steno Diabetes Center - Gentofte, Denmark
The DETECT-2 study

Stefanie Eising - Steno Diabetes Center - Gentofte, Denmark
EFSD repository for confirmatory studies on type 1 diabetes genetic markers